• About
        • About ACTA
        • Our vision and mission
        • Why ACTA formed
        • Our members
        • Our Board
        • Our team
        • Our annual reports
        • Our policies
  • Activities
        • Our current activities
        • Clinical Quality Registries SIG (CQR SIG)
        • SIGNeT
        • Statistics in Trials SIG (STInG)
        • Advocacy
  • News
  • Resources
        • View our resource library
        • ACTA resources
        • Sector resources
        • DSMB directory (STInG members only)
        • Find a health economist
        • Find a statistician (STInG members only)
        • Sector careers board
  • Events
  • Get involved
        • About ACTA membership
        • Our members
  • Contact Us
  1. Home
  2. Find a health economist
  3. Dr Rashidul Alam Mahumud

Dr Rashidul Alam Mahumud

Research Fellow-Health Economist

PhD in Health Economics in 2020

rashed.mahumud@sydney.edu.au

Back to search

State: NSW

Clincial areas of expertise:

Economic evaluation, discrete choice experiments and budget impact analysis

Methodological areas of expertise

Cost effectiveness modelling, Health economic evaluation alongside adaptive trials, Health economic evaluation alongside registry-randomised trials, Trial-based economic evaluation, Stated preference studies (e.g. discrete choice experiments), Analysing linked administrative data, Economic evaluation in LMIC, Budget impact analysis

3 main areas of health economics/ clinical trial expertise

Oncology, Disease burden, Psychological medicine

Online Citations:

1. Mahumud RA, Law CK, Morton RL. Economic Evaluation of Inguinal Versus Ilio-Inguinal Lymphadenectomy Surgery for Patients with Stage III Metastatic Melanoma to Groin Lymph Nodes: Evidence from an International Randomised Trial [accepted in iHEA conference 2023 (manuscript preparation ongoing)]

2. Mahumud RA, Gow J, Alam K, Keramat SA, Hossain MG, Sultana M, Sarker AR, Islam SM. Cost-effectiveness of the introduction of two-dose bi-valent (Cervarix) and quadrivalent (Gardasil) HPV vaccination for adolescent girls in Bangladesh. https://doi.org/10.1016/j.vaccine.2019.10.037

3. Mahumud RA, Alam K, Dunn J, Gow J. The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia. PLoS ONE; 2019;14(10):e0223658.https://doi.org/10.1371/journal.pone.0223658

Quick links

  • About ACTA
  • Activities
  • Events
  • Resources library

Membership

Open to clinical trials networks, clinical trial coordinating centres and clinical quality registries that support ACTA’s mission and vision and meet the membership criteria outlined.

Login Learn More

Newsletter

Be the first to know all ACTA events and featured news through our Newsletter.

You don’t need to be a member to subscribe!

Contact us

+61 3 8639 0770

Suite 1, L2 / 24 Albert Road
Melbourne VIC 3205 Australia

Social Media

  • Twitter
  • LinkedIn

Copyright © 2023 Australian Clinical Trials Alliance | ABN: 60 168 693 972 | Privacy Statement | Sitemap

Website by Marameo Design

Login

Lost Password?Become a member